MHRA Phase I Accreditation Certificate (October 2023)
The accreditation is based on the Unit continuing to maintain satisfactory standards for avoiding harm to trial subjects and for handling medical emergencies should they arise.
MHRA Phase I Accreditation Certificate (01 June 2022)
The accreditation is based on the Unit continuing to maintain satisfactory standards for avoiding harm to trial subjects and for handling medical emergencies should they arise.
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
.svg){kind=small}
.avif)
